Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. - Wikidata - awgldk - TriplyDB

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.

http://www.wikidata.org/entity/Q47669931

about

RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomas.Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma.ZNF545 suppresses human hepatocellular carcinoma growth by inhibiting NF-kB signaling.Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome.Molecular classification of low-grade diffuse gliomas.Correlation between cerebral blood volume measurements by perfusion-weighted magnetic resonance imaging and two-year progression-free survival in gliomas.MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.The importance of 10q status in an outcomes-based comparison between 1p/19q fluorescence in situ hybridization and polymerase chain reaction-based microsatellite loss of heterozygosity analysis of oligodendrogliomas.Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.Genetic pathways to primary and secondary glioblastoma Detection of 1p19q deletion by real-time comparative quantitative PCR.Combination genetic signature stratifies lower-grade gliomas better than histological grade.Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas.Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival.A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors.Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.Long-term molecular changes in WHO grade II astrocytomas following radiotherapy Phospholipase C Beta 1: a Candidate Signature Gene for Proneural Subtype High-Grade Glioma.Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.Radiological imaging features of glioblastoma with oligodendroglioma component: a comparison with conventional glioblastoma.Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.Low-grade oligodendroglioma: current treatments and future hopes.Genetic profile of astrocytic and oligodendroglial gliomas.Long-term epilepsy-associated tumors.IDH mutations in human glioma Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management.IDH mutation is associated with higher risk of malignant transformation in low-grade glioma.Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.Diagnostic, prognostic and predictive relevance of molecular markers in gliomas.Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion.

P2860

Q24322861-9F7A10B1-9E1B-4B38-A426-E9C92498B39B Q24656269-0DC10180-FF21-4A2F-BD53-5AA80C261CCB Q29976922-A8EEC8ED-9EE4-45C9-9F47-732E72C5E621 Q30444816-D83246B0-8578-432C-A4DE-9062DBD7BE89 Q33396947-BF10B846-25DC-465D-8D63-EA1698D1309E Q33399939-44FCBE1F-0E11-4BD0-8BFC-26251B518517 Q33849703-E7199806-FCDC-476B-8F8F-EC81F4A7821E Q34116278-E06D87BF-87C1-421F-9F45-ADF6CDA31E27 Q34277659-A1E5E458-0C29-4B77-A119-280F0AE6E987 Q34358250-D740B081-4E58-4E1E-965F-5E2E990D13B6 Q34369456-F6337686-A953-44BA-B1FF-EE7BCB262446 Q34507966-1DB0FB3E-AD8E-4A74-A46C-A555DB55FEEA Q35418206-BEF90E56-4518-4F26-80F5-9B06793C42BA Q35419344-1213400E-E61B-4CB3-A4F1-4B4A1AFA13C2 Q35633835-72844DA6-2BB5-400C-BBA7-1281E535855E Q35634042-3F736856-1D9B-46A5-AAFA-E4CC3686D666 Q35673519-2987E05F-460D-4B92-9305-B4A2AAC8A89C Q35675684-9EF2796D-196D-4152-A6B8-0C8A8AA6BDC5 Q35757144-D9416725-2BA3-4F52-81E0-BDBC51A7F4D2 Q35789635-3B2C2E3B-7B58-4B10-B381-9751FE3A5F56 Q36356194-5C97BFCB-CC98-45AB-8F40-A494675DDF96 Q36401835-89B5E840-B434-4211-9174-8447380E5AEA Q36546013-236FBEFE-C4B2-485C-8E42-CCA6615607CC Q36713478-10AE79ED-F808-4DB9-806C-1B092E9DD941 Q36919406-6D15855F-63FA-45D2-94AC-2342CE6905A3 Q37055286-0D51DDAF-0DF3-4409-99B2-9C7B4B3BE1B8 Q37183666-315DA353-9ECD-4BF9-A979-ED577B221584 Q37377830-B82C9C22-59B7-4835-A671-141AECED6EF0 Q37409721-7658960A-3169-45F3-8701-6E0C7BDCF4DA Q37436717-7C7B4956-AEFC-4257-9F12-9CFFE4F12F1A Q37601178-C981A7C5-536C-488A-A149-FCAE0EBA0EE8 Q37628706-C6280ADD-DC32-4F7A-8127-DE2CE9746382 Q37858440-55FA4DBC-F2FB-4AF8-9DCE-F9CB90F7181A Q38002123-C1EBB01E-8FC9-43F8-AD22-0517EAAF26E1 Q38022856-01BEBDCC-5BBF-4702-A944-C2B613AF5A49 Q38233116-9C773724-6960-4EF4-9DD8-3FE1069AA471 Q38382618-5297F03E-BE16-400F-9F05-6AE3053C86A2 Q38409615-ABC61EDE-EDA8-43F4-BB20-CD01D2F8AFA5 Q38461565-C6F8369E-E163-4D37-952C-F44B62F2B3F7 Q38482332-B6D91CBD-6FE8-46C2-94F5-9F25A52B0A11

P2860

Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.

http://www.wikidata.org/entity/Q47669931

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Population-based study on inci ...... ytomas and oligodendrogliomas.

@en

Population-based study on inci ...... ytomas and oligodendrogliomas.

@nl

type

label

Population-based study on inci ...... ytomas and oligodendrogliomas.

@en

Population-based study on inci ...... ytomas and oligodendrogliomas.

@nl

prefLabel

Population-based study on inci ...... ytomas and oligodendrogliomas.

@en

Population-based study on inci ...... ytomas and oligodendrogliomas.

@nl

P1433

Q47669931-83F55FB2-176E-4E01-81AD-4E1BBC752C08

P1476

Q47669931-C33D04F6-2032-4CC5-B972-2B81372CA748

P2093

Q47669931-0077444B-3A88-495D-87AF-9D14097BED93

Q47669931-454F6154-E6FF-4541-8243-E94D4A6A284D

Q47669931-4F7B3B7D-DC72-431B-8F69-25EA30ECBE4D

Q47669931-7A613446-42EE-4531-ABA0-9C56B519C0A5

Q47669931-9C1629BB-3FD7-48D6-9601-FE4276200CE2

Q47669931-A1F3B848-2A29-4448-957C-7B9DF79650EB

Q47669931-B18498AE-E64A-4606-B0BC-81CB46C7EA24

Q47669931-BAFE4FBA-8C51-4453-BF18-E8F11BBF6D91

Q47669931-BF51CFEC-5E7C-45E3-A400-799C1B2F7DE7

Q47669931-C500C364-15FB-44CD-8BC7-2D288098A005

P2888

Q47669931-077482E7-DF5A-4AD9-A332-9EA5F5D29E60

P304

Q47669931-A73D5DEC-9E23-4BCA-B479-927AAD665548

P31

Q47669931-0FBE4CBE-A6AB-4FBC-8E16-44603EDB7C6B

P356

Q47669931-38BF4921-1DD0-42C8-8F2B-B402C271E702

P433

Q47669931-693AB22C-74A5-4136-96E4-BD943683E16B

P478

Q47669931-27266055-A6EA-49E9-91C7-9AFF8AE87EE6

P50

Q47669931-AECE053A-75EE-42F1-A368-0DA776056FA2

P577

Q47669931-5F4D74B0-610C-49A1-B471-20DBCAB4047F

P698

Q47669931-488F3065-36E1-4EE5-917D-538A7DF055F6

P921

Q47669931-C97FA055-1F04-4BBE-9B72-C6A804CDD1D5

P356

S00401-004-0861-Z

P1433

Acta Neuropathologica

P1476

Population-based study on inci ...... ytomas and oligodendrogliomas.

@en

P2093

Benjamin Jourde

http://www.w3.org/2001/XMLSchema#string

Christoph Burkhard

http://www.w3.org/2001/XMLSchema#string

Danielle Schüler

http://www.w3.org/2001/XMLSchema#string

Hiroko Ohgaki

http://www.w3.org/2001/XMLSchema#string

M Gazi Yasargil

http://www.w3.org/2001/XMLSchema#string

Nicole M Probst-Hensch

http://www.w3.org/2001/XMLSchema#string

Paul Kleihues

http://www.w3.org/2001/XMLSchema#string

Pier-Luigi Di Patre

http://www.w3.org/2001/XMLSchema#string

Sonja Horstmann

http://www.w3.org/2001/XMLSchema#string

Urs M Lütolf

http://www.w3.org/2001/XMLSchema#string

P2888

s00401-004-0861-z

P304

49-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-004-0861-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Michael T Fahey

P577

2004-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15118874

http://www.w3.org/2001/XMLSchema#string

P921

oligodendroglioma